Comerica Bank cut its position in HB Fuller Co (NYSE:FUL) by 3.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 136,204 shares of the specialty chemicals company’s stock after selling 4,932 shares during the period. Comerica Bank’s holdings in HB Fuller were worth $6,539,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. California Public Employees Retirement System grew its stake in shares of HB Fuller by 17.9% in the 3rd quarter. California Public Employees Retirement System now owns 121,903 shares of the specialty chemicals company’s stock valued at $5,676,000 after buying an additional 18,493 shares during the period. S&CO Inc. grew its stake in shares of HB Fuller by 1.0% in the 3rd quarter. S&CO Inc. now owns 246,577 shares of the specialty chemicals company’s stock valued at $11,481,000 after buying an additional 2,493 shares during the period. Pegasus Partners Ltd. grew its stake in shares of HB Fuller by 111.3% in the 3rd quarter. Pegasus Partners Ltd. now owns 29,889 shares of the specialty chemicals company’s stock valued at $1,392,000 after buying an additional 15,744 shares during the period. Rhumbline Advisers grew its stake in shares of HB Fuller by 3.3% in the 3rd quarter. Rhumbline Advisers now owns 167,694 shares of the specialty chemicals company’s stock valued at $7,808,000 after buying an additional 5,335 shares during the period. Finally, AdvisorNet Financial Inc acquired a new stake in shares of HB Fuller in the 3rd quarter valued at about $127,000. Institutional investors own 97.48% of the company’s stock.
In other news, VP Timothy J. Keenan sold 8,322 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $51.78, for a total value of $430,913.16. Following the transaction, the vice president now owns 32,039 shares in the company, valued at approximately $1,658,979.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Robert J. Martsching sold 1,700 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $49.29, for a total value of $83,793.00. The disclosure for this sale can be found here. Insiders have sold a total of 46,944 shares of company stock valued at $2,226,146 in the last quarter. Company insiders own 3.46% of the company’s stock.
FUL has been the subject of a number of analyst reports. Deutsche Bank set a $50.00 price target on HB Fuller and gave the company a “hold” rating in a research note on Friday, September 27th. Zacks Investment Research downgraded HB Fuller from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 1st. Citigroup downgraded HB Fuller from a “neutral” rating to a “sell” rating and cut their price target for the company from $48.00 to $41.00 in a research note on Friday, September 27th. Buckingham Research set a $60.00 price target on HB Fuller and gave the company a “buy” rating in a research note on Thursday, September 26th. Finally, TheStreet upgraded HB Fuller from a “c+” rating to a “b-” rating in a research note on Tuesday, July 23rd. Two analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company’s stock. HB Fuller presently has an average rating of “Hold” and an average target price of $51.80.
FUL stock opened at $51.20 on Thursday. The company has a market capitalization of $2.61 billion, a P/E ratio of 17.17, a price-to-earnings-growth ratio of 1.66 and a beta of 1.57. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.55 and a current ratio of 2.36. HB Fuller Co has a 52-week low of $39.22 and a 52-week high of $52.12. The business has a 50-day simple moving average of $47.74 and a two-hundred day simple moving average of $45.88.
HB Fuller (NYSE:FUL) last released its quarterly earnings results on Wednesday, September 25th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.04). The company had revenue of $725.38 million for the quarter, compared to analyst estimates of $749.18 million. HB Fuller had a net margin of 4.78% and a return on equity of 13.20%. HB Fuller’s revenue for the quarter was down 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 EPS. As a group, sell-side analysts forecast that HB Fuller Co will post 3 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Thursday, October 17th were paid a dividend of $0.16 per share. The ex-dividend date was Wednesday, October 16th. This represents a $0.64 dividend on an annualized basis and a yield of 1.25%. HB Fuller’s dividend payout ratio (DPR) is currently 21.33%.
About HB Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
Featured Story: What member countries make up the G-20?
Want to see what other hedge funds are holding FUL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HB Fuller Co (NYSE:FUL).
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.